StefanPulstMDDr. med
Neurology • Salt Lake City, UTMovement Disorder, Neurodegenerative
Professor and Chair, Department of Neurology, University Utah
Dr. Pulst is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
50 N Medical Dr
University of Utah, Clinical Neurosciences Ctr
Salt Lake City, UT 84132Phone+1 801-585-2886
Summary
- Dr. Stefan Pulst is a neurologist in Salt Lake City, UT and is affiliated with University of Utah Health. He received his medical degree from Hannover Medical School (MHH), trained in neurology at MHH and at Harvard Medical School, and has been in practice 38 years. He specializes in movement disorder and neurodegenerative and is experienced in general neurology, movement disorders, and inherited ataxias. He was awarded the Cotzias Award for Neuroscience and the Singhal award in Movement Disorder Research.
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Neurology, 1981 - 1983
MH HannoverGermany, Neurology, 1980 - 1981
Hannover Medical SchoolClass of 1979
Certifications & Licensure
CA State Medical License 1985 - Present
UT State Medical License 2008 - 2026- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- AAAS Elected Fellow American Association for the Advancement of Science, 2021
- Singhal Award World Federation of Neurology, 2017
- Senator Jacob Javits Award for Neuroscience National Institute of Neurological Disorders and Stroke, 2014
- Join now to see all
Clinical Trials
- Natural History Study of and Genetic Modifiers in Spinocerebellar Ataxias Start of enrollment: 2010 Apr 01
- Clinical Trial Readiness for SCA1 and SCA3 Start of enrollment: 2018 Aug 16
Publications & Presentations
PubMed
- 8 citationsCholecystokinin 1 receptor activation restores normal mTORC1 signaling and is protective to Purkinje cells of SCA mice.Emily A.L. Wozniak, Zhao Chen, Sharan Paul, Praseuth Yang, Karla P. Figueroa
Cell Reports. 2021-10-12 - 97 citationsMutations of the neurofibromatosis type 2 gene and lack of the gene product in vestibular schwannomasJesús Sainz, Duong P. Huynh, Karla P. Figueroa, Nikola K. Ragge, Michael E. Baser
Human Molecular Genetics. 1994-06-01 - 1010 citationsAlteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2Guy A. Rouleau, P. Merel, Mohini Lutchman, Marc Sanson, Jessica Zucman
Nature. 1993-06-10
Journal Articles
- sca2pulst, Nature Genetics
Press Mentions
Neurology Editors Identify the Red Flags of Predatory PublishingOctober 3rd, 2019
Protein Staufen1 Could Be Target for Future ALS Therapies, Mouse Study SuggestsSeptember 13th, 2018
Potential Drug Target Found for Spinocerebellar Ataxia Type 2September 10th, 2018- Join now to see all
Grant Support
- ATXN2-complex proteinsNINDS2021–2027
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
